Previous 10 | Next 10 |
Sorrento Therapeutics (NASDAQ: SRNE ), which rose 160% last Friday after an interview with Fox in which they discussed their potential project which could work better than a vaccine for COVID-19, drops quickly into negative territory after Hindenburg Research, a short-seller of the name, fla...
Novel TKI compound with dual selective targeting of mutant forms of EGFR and BTK More than 600 patients have been treated with the compound across studies, with over 200 patients in the completed registrational trial SAN DIEGO, May 21, 2020 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, I...
Money Minting - Theory and Practice Usually, when investors refer to MMT, they mean Modern Monetary Theory , a macroeconomic framework that basically says monetarily sovereign countries like the U.S. do not need taxes or borrowing for spending since they can print as much as they need and...
In an interview on Yahoo Finance, Sorrento Therapeutics ( SRNE +6.5% ) founder and CEO Dr. Henry Ji said that he expects to get FDA sign-off to start clinical trials on its self-proclaimed neutralizing antibody "cure" for COVID-19, STI-1499, in the next 2-3 months. More news on: Sorren...
Shares of Sorrento Therapeutics (NASDAQ: SRNE) were sinking 11.5% lower as of 11:34 a.m. EDT on Wednesday. There weren't any new developments to cause Sorrento's shares to fall. Instead, it appears that investors continued to think that the stock's huge gain following the drugmaker's annou...
"I suggest extreme skepticism regarding any claims made by Sorrento (NASDAQ: SRNE )," one former employee tells Hindenburg Research. "I would never in my life have put out a press release where I say we have a cure," says a former executive. More news on: Sorrento Therapeutics, Inc., OPKO ...
Pyxus International (NYSE: PYX ) -26% . More news on: Pyxus International, Inc., Nano Dimension Ltd., Medigus Ltd., Stocks on the move, , Read more ...
Sorrento (SRNE) was Friday's headline trade. The company's CEO stunned the world by claiming that Sorrento had a 100% efficient cure for COVID-19. Investors and speculators alike flocked to the company's stock and sent the price to the moon. This is one of those cases where you have to act fas...
Many drugmakers are rushing to develop potential therapies and vaccines for novel coronavirus disease COVID-19. But two of them have been in the spotlight in recent days. Moderna (NASDAQ: MRNA) announced positive interim data on Monday from an early-stage clinical study of its COVID-1...
After jumping as much as 282% from Thursday's closing price to the high yesterday, Sorrento Therapeutics (NASDAQ: SRNE) dropped 16.6% on Tuesday on no apparent news -- other than, of course, that the biotech had jumped a 282% in less than two trading days, followed by a dose of reality as it...
News, Short Squeeze, Breakout and More Instantly...
Sorrento Therapeutics Inc. Company Name:
SRNE Stock Symbol:
NASDAQ Market:
Sorrento Therapeutics Inc. Website:
What goes up usually comes down, and that's exactly what happened with Sorrento Therapeutics (NASDAQ: SRNE) today. Shares of Sorrento were crashing 30.4% as of 3:38 p.m. ET on Wednesday after soaring more than 60% on Tuesday. Sorrento's huge surge yesterday came after the company anno...
A California-based %Biotech company is turning heads Wednesday morning after it was announced that the U.S. Bankruptcy Court granted an interim approval of the company’s $75 million debtor-in-possession financing. While bankruptcy court can get a little messy, traders seem to b...